Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3b/4 clinical study ...

Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease that significantly impacts quality of life and often ...

Nektar Therapeutics is fairly valued based on rNPV modeling, but multiple near-term catalysts could drive upside. Learn why ...

Treatment of atopic dermatitis There is no complete cure for atopic dermatitis. A systemic, prolonged approach must be used to keep the disease in control.

"The study adds to growing evidence that dupilumab, while highly effective for managing atopic dermatitis, may also be linked ...

A large trial in a primary care setting found daily emollient use to be safe, feasible, and effective in reducing atopic ...

Patients with type 2 diabetes and atopic dermatitis show higher risk for cardiovascular events, but GLP-1 agonists reduce the ...

J Am Acad Dermatol 1994;30 (1):35-9 4. Illi S. and al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma J Allergy Clin Immunol 2004;113 (5):925-931 5.

Key opinion leaders provide a concise overview of the atopic dermatitis (AD) treatment landscape, focusing on the role of topical therapy, and highlight the current unmet needs in AD management.

Atopic Dermatitis Follow along on our guide to Atopic Dermatitis, an exploration of the latest recommendations and research on diagnosis, treatment, and management of this common and usually ...

Video > Atopic Dermatitis Video Pearls Improving Treatment Adherence in Atopic Dermatitis — We've got great treatments, says Steven Feldman, the key is getting patients to use them by Greg Laub ...